Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- LYMErix (lyme disease vaccine)
- tacrolimus
Interactions between your drugs
tacrolimus Lyme disease vaccine
Applies to: tacrolimus, LYMErix (lyme disease vaccine)
GENERALLY AVOID: The administration of Lyme disease vaccine to immunosuppressed patients may be associated with a diminished or suboptimal immunologic response due to antibody inhibition. Such patients may include those who have recently received or are receiving immunosuppressive agents, antilymphocyte globulins, alkylating agents, antimetabolites, radiation, some antirheumatic agents, high dosages of corticosteroids or adrenocorticotropic agents (greater than 10 mg/day to 1 mg/kg/day, whichever is less, of prednisone or equivalent for more than 2 weeks), or long-term topical or inhaled corticosteroids.
MANAGEMENT: The manufacturer suggests considering deferral of vaccination against Lyme disease until 3 months after discontinuation of immunosuppressive therapy. Vaccines may generally be administered to patients receiving corticosteroids as replacement therapy (e.g., for Addison's disease).
References (1)
- "Product Information. LYMErix (Lyme disease vaccine)." SmithKline Beecham
Drug and food interactions
tacrolimus food
Applies to: tacrolimus
ADJUST DOSING INTERVAL: Consumption of food has led to a 27% decrease in the bioavailability of orally administered tacrolimus.
MANAGEMENT: Tacrolimus should be administered at least one hour before or two hours after meals.
GENERALLY AVOID: Grapefruit juice has been reported to increase tacrolimus trough concentrations. Data are limited, but inhibition of the CYP450 enzyme system appears to be involved.
MANAGEMENT: The clinician may want to recommend that the patient avoid ingesting large amounts of grapefruit juice while taking tacrolimus.
References (2)
- (2001) "Product Information. Prograf (tacrolimus)." Fujisawa
- Hooks MA (1994) "Tacrolimus, a new immunosuppressant--a review of the literature." Ann Pharmacother, 28, p. 501-11
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Bexsero
Bexsero is used for meningitis, meningococcal, meningococcal disease prophylaxis
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Biothrax
BioThrax is used to help prevent anthrax in people exposed to the bacteria through the skin or ...
Capvaxive
Capvaxive (pneumococcal 21-valent conjugate vaccine) is a single-dose vaccine that may be used to ...
Cyfendus
Cyfendus (anthrax vaccine adsorbed, adjuvanted) is a vaccine indicated for the post-exposure ...
Hiberix
Hiberix vaccine is used to prevent infection caused by haemophilus B bacteria. Learn about side ...
Liquid PedvaxHIB
Liquid PedvaxHIB is used for haemophilus influenzae prophylaxis
Menactra
Menactra is used to prevent infection caused by meningococcal bacteria. Learn about side effects ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.